Fig. 4From: Incidence and risk of hypertension in patients newly treated for multiple myeloma: a retrospective cohort studyAddition of anti-hypertensive medications during the follow-up period for MM and non-MM patients. Classes of anti-hypertensive medications added included diuretics, ACE-I, angiotensin II blockers, calcium channel blockers and other (alpha blockers, alpha-2 receptor agonists, beta-blockers, central agonists, combined alpha and beta blockers, peripheral adrenergic inhibitors, renin inhibitors and vasodilators). ACE-I, angiotension-converting enzyme inhibitor; MM, multiple myelomaBack to article page